ZEO ScientifiX launches expansion initiative following Florida's new stem cell law

Zeo ScientifiX, Inc.

Florida's SB-1768, effective July 1, 2025, authorizes non-FDA-approved stem cell therapies for defined conditions.
ZEO launched a redesigned website (www.zeoscientifix.com) and partnered with Plus4 PR and Small Circle for brand growth.
CEO Ian Bothwell expects additional states to follow, positioning ZEO to lead with its cGMP-compliant biologics platform.
ZEO aims to set the industry standard via ethically sourced biologics, physician education, and compliant product inventory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.